Year |
Citation |
Score |
2023 |
Dailey KM, Small JM, Pullan JE, Winfree S, Vance KE, Orr M, Mallik S, Bayles KW, Hollingsworth MA, Brooks AE. An intravenous pancreatic cancer therapeutic: Characterization of CRISPR/Cas9n-modified Clostridium novyi-Non Toxic. Plos One. 18: e0289183. PMID 37963142 DOI: 10.1371/journal.pone.0289183 |
0.67 |
|
2023 |
Roe JM, Seely K, Bussard CJ, Eischen Martin E, Mouw EG, Bayles KW, Hollingsworth MA, Brooks AE, Dailey KM. Hacking the Immune Response to Solid Tumors: Harnessing the Anti-Cancer Capacities of Oncolytic Bacteria. Pharmaceutics. 15. PMID 37514190 DOI: 10.3390/pharmaceutics15072004 |
0.672 |
|
2022 |
Pullan J, Dailey K, Bhallamudi S, Feng L, Alhalhooly L, Froberg J, Osborn J, Sarkar K, Molden T, Sathish V, Choi Y, Brooks A, Mallik S. Modified Bovine Milk Exosomes for Doxorubicin Delivery to Triple-Negative Breast Cancer Cells. Acs Applied Bio Materials. PMID 35417133 DOI: 10.1021/acsabm.2c00015 |
0.621 |
|
2021 |
Pierce KM, Miklavcic WR, Cook KP, Hennen MS, Bayles KW, Hollingsworth MA, Brooks AE, Pullan JE, Dailey KM. The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors. Nanomaterials (Basel, Switzerland). 11. PMID 34835785 DOI: 10.3390/nano11113018 |
0.678 |
|
2021 |
Dailey KM, Jacobson RI, Johnson PR, Woolery TJ, Kim J, Jansen RJ, Mallik S, Brooks AE. Methods and Techniques to Facilitate the Development of NT as an Effective, Therapeutic Oncolytic Bacteria. Frontiers in Microbiology. 12: 624618. PMID 33854487 DOI: 10.3389/fmicb.2021.624618 |
0.685 |
|
2021 |
Dailey KM, Allgood JE, Johnson PR, Ostlie MA, Brooks BD, Brooks AE, Schaner KC. The next frontier of oncotherapy: accomplishing clinical translation of oncolytic bacteria through genetic engineering. Future Microbiology. PMID 33754804 DOI: 10.2217/fmb-2020-0245 |
0.685 |
|
2019 |
Shreffler JW, Pullan JE, Dailey KM, Mallik S, Brooks AE. Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification. International Journal of Molecular Sciences. 20. PMID 31801303 DOI: 10.3390/Ijms20236056 |
0.63 |
|
Show low-probability matches. |